Julianne Bruno - 09 Feb 2026 Form 4 Insider Report for Galecto, Inc. (GLTO)

Role
Director
Signature
/s/ Lori Firmani, attorney-in-fact
Issuer symbol
GLTO
Transactions as of
09 Feb 2026
Net transactions value
$0
Form type
4
Filing time
12 Feb 2026, 06:05:08 UTC
Previous filing
17 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bruno Julianne Director C/O GALECTO, INC.,, 75 STATE STREET, SUITE 100, BOSTON /s/ Lori Firmani, attorney-in-fact 12 Feb 2026 0002019645

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLTO Common Stock Options Exercise $0 +129,000 +1606% $0.000000 137,032 09 Feb 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLTO Series C Preferred Stock Options Exercise $0 -129 -100% $0.000000 0 09 Feb 2026 Common Stock 129,000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 9, 2026, the Issuer's stockholders approved the issuance of Common Stock upon conversion of the Issuer's Series C Non-Voting Convertible Preferred Stock, par value $0.00001 per share ("Series C Preferred Stock") (the "Requisite Stockholder Approval"). Accordingly, pursuant to the terms of the Certificate of Designations of Preferences, Rights and Limitations of Series C Non-Voting Convertible Preferred Stock, 129 shares of Series C Preferred Stock held by the Reporting Person were converted into 129,000 shares of Common Stock. The securities of the Issuer held by the Reporting Person, including the shares of Common Stock received upon conversion of the Series C Preferred Stock, are subject to the terms a lock-up agreement entered into with the underwriters for the Issuer's public offering, pursuant to which the Reporting Person agreed, subject to certain exceptions, not to directly or indirectly sell or otherwise transfer securities of the Issuer for a period of 60 days
F2 (Continued from footnote 1) following the date of the final prospectus supplement relating to the public offering, which was February 10, 2026.
F3 Following receipt of the Requisite Stockholder Approval, each share of Series C Preferred Stock automatically converted into 1,000 shares of Common Stock, subject to certain beneficial ownership limitations. The Series C Preferred Stock has no expiration date.